(Q37077751)

18 August 2017

Metabolic and clinical consequences of hyperthyroidism on bone density (English)

1 reference

18 August 2017

Jagoda Gorka

1

1 reference

18 August 2017

Regina M Taylor-Gjevre

series ordinal

2

1 reference

18 August 2017

Terra Arnason

series ordinal

3

1 reference

18 August 2017

22 July 2013

1 reference

International journal of endocrinology

18 August 2017

1 reference

18 August 2017

2013

1 reference

18 August 2017

638727

1 reference

Creative Commons Attribution 3.0 Unported

18 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The skeletal consequences of thyrotoxicosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Subclinical thyroid dysfunction and incident hip fracture in older adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Cellular and molecular mechanisms of bone remodeling.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The skeletal phenotypes of TRalpha and TRbeta mutant mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The rat thyroid hormone receptor (TR) Deltabeta3 displays cell-, TR isoform-, and thyroid hormone response element-specific actions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Disorders of calcium metabolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Subclinical hyperthyroidism: clinical features and treatment options

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The thyroid and the skeleton

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Thyroid hormones: beneficial or deleterious for bone?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The molecular actions of thyroid hormone in bone

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The TSH receptor reveals itself.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Molecular mechanisms of thyroid hormone effects on bone growth and function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The effect of thyroid hormone on skeletal integrity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The effect of olpadronate in ovariectomized thyroxine-treated rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Thyroid hormones and bone

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Effect of hyperthyroidism and its treatment on bone mineral content

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Effects of thyroid hormones on bone and mineral metabolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Estrogens, bone loss and preservation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Radioiodine therapy in elderly patients with subclinical hyperthyroidism due to non-voluminous nodular goiter and its effect on bone metabolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Risk for fracture in women with low serum levels of thyroid-stimulating hormone

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Fractures following thyroidectomy in women: a population-based cohort study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone Turnover in Overt and Subclinical Hyperthyroidism Due to Autonomous Thyroid Adenoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Phalangeal quantitative ultrasound and bone mineral density in evaluating cortical bone loss: a study in postmenopausal women with primary hyperparathyroidism and subclinical iatrogenic hyperthyroidism

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Thyroid status during skeletal development determines adult bone structure and mineralization

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Treatment of osteoporosis with antiresorptive drugs

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Osteoporosis treatment in elderly hyperthyroid male patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Hip fractures and the thyroid: a case-control study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Plasma levels of ionised calcium and magnesium in thyroid disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736466

Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F638727

Exogenous hyperthyroidism with osteoporosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F638727

Relationship between Subclinical Thyroid Dysfunction and Femoral Neck Bone Mineral Density in Women

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F638727

Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers

21 January 2018

1 reference

12 December 2020

Fracture risk in patients treated for hyperthyroidism

1 reference

12 December 2020

Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation

1 reference

12 December 2020

Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves' disease with subclinical hyperthyroidism

1 reference

12 December 2020

Alkaline Phosphatase Isoenzyme Patterns in Hyperthyroidism

1 reference

12 December 2020

[Bone mineral density in primary hyperparathyroidism]

1 reference

12 December 2020

Exogenous hyperthyroidism with osteoporosis

1 reference

12 December 2020

Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women

1 reference

12 December 2020

Steatorrhea in thyrotoxicosis. Relation to hypermotility and excessive dietary fat

1 reference

12 December 2020

Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans

1 reference

12 December 2020

Changes in body composition in women following treatment of overt and subclinical hyperthyroidism

1 reference

12 December 2020

Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism

1 reference

12 December 2020

The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study

1 reference

12 December 2020

Evaluation of bone mineral density in thyrotoxicosis

1 reference

12 December 2020

Osteoporosis and fractures following thyrotoxicosis

1 reference

12 December 2020

Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism

1 reference

12 December 2020

Bone changes in hyperthyroidism--a preliminary study

1 reference

12 December 2020

Elevated metabolic clearance rate of 1 alpha,25-dihydroxyvitamin D3 in hyperthyroidism

1 reference

12 December 2020

Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?

1 reference

12 December 2020

Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen

1 reference

12 December 2020

Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate

1 reference

12 December 2020

Serum bone Gla protein: a marker of bone turnover in hyperthyroidism

1 reference

12 December 2020

Bone mineral density in hyperthyroidism

1 reference

12 December 2020

Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women

1 reference

12 December 2020

The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover

1 reference

12 December 2020

Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre

1 reference

12 December 2020

Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women

1 reference

12 December 2020

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis

1 reference

12 December 2020

Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism

1 reference

12 December 2020

Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom

1 reference

12 December 2020

Subclinical thyroid disease

1 reference

12 December 2020

A comparative study of bone mineral density between premenopausal women with hyperthyroidism and healthy premenopausal women

1 reference

12 December 2020

Approach to the patient with subclinical hyperthyroidism

1 reference

12 December 2020

Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin

1 reference

12 December 2020

Trabecular bone mineralization lag time determined by tetracycline double-labeling in normal and certain pathological conditions

1 reference

12 December 2020

Secondary osteoporosis

1 reference

12 December 2020

Bone and heart abnormalities of subclinical hyperthyroidism in women below the age of 65 years

1 reference

12 December 2020

[Osseous effects of hyperthyroidism]

1 reference

12 December 2020

Trabecular bone remodeling and bone balance in hyperthyroidism

1 reference

12 December 2020

Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis

1 reference

12 December 2020

Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism?

1 reference

12 December 2020

Osteoporosis in hyperthyroidism estimated by photon absorptiometry

1 reference

12 December 2020

Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy

1 reference

12 December 2020

TSH Is a Negative Regulator of Skeletal Remodeling

1 reference

12 December 2020

Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine

1 reference

12 December 2020

Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole

1 reference

12 December 2020

Effect of replacement doses of thyroxine on bone mineral density

1 reference

12 December 2020

Is previous hyperthyroidism still a risk factor for osteoporosis in post‐menopausal women?

1 reference

12 December 2020

Thyrotoxic bone disease in women: a potentially reversible disorder

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/638727

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

23970897

1 reference